Effect of Binder Type and Binder Level on the Properties of Agglomerates Containing Lactose and Dibasic Calcium Phosphate Dihydrate - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Effect of Binder Type and Binder Level on the Properties of Agglomerates Containing Lactose and Dibasic Calcium Phosphate Dihydrate
The authors studied the effect of the combination of binders on the flow and compressibility characteristics of the agglomerates of binary combination of lactose and dibasic calcium phosphate dihydrate.


Pharmaceutical Technology
Volume 32, Issue 10, pp. 54-64

Disintegration time. A disintegration test was performed using standard disintegration test apparatus (model ED2, Electrolab, India) at 37 C in 900 mL of distilled water for six tablets in accordance with USP 24 (19).

In vitro dissolution study. An in vitro dissolution study of the tablets was carried out in phosphate buffer (pH 5.8, 900 mL, 37 0.5 C) using USP 23 paddle apparatus (50 rpm). Samples (5 mL) were withdrawn at predetermined time intervals, filtered through 0.45 αm filter, and assayed at 246 nm using a UV–vis spectrophotometer (Jasco V530, Japan) to determine the percentage of drug released. The same volume (5 mL) of fresh dissolution medium (37 0.5 C) was replenished immediately after the sample was withdrawn (20).

Results and discussion


Table IV: Regression analysis data for the parameters evaluated as per Plackett-Burman experimental design.
Analysis of the data. The response parameters were fitted to a first-order polynomial model Y = B 0 + B 1 X 1 + B 2 X 2 + B 3 X 3+ B 4 X 4 + B 5 X 5 + B 6 X 6 by performing multiple linear regression analysis using Design Expert 7.13 trial (Statease stastical software package). ANOVA was performed on the response parameters to identify the statistically significant factors (see Table IV).

Evaluation of agglomerates. Angle of repose (Y 1). Regression analysis showed that acacia has the highest effect on angle of repose, but the value of its coefficient is positive, which indicates that as the amount of acacia increases, the value of angle of repose increases, resulting in poor flow. Starch was the best in improving the flow properties. Although the remaining four excipients had similar effect in improving the flow properties, the effect was less pronounced than when starch was used.

Carr's index (Y2). HPMC, starch, and silicon dioxide, when used for granulation, had significant effects (p < 0.01) on the compressibility index. The negative sign of their coefficients indicates that they reduce the compressibility index values and thus yield agglomerates with better flow. Guar gum and PEG also improved flow but to a lesser extent. Acacia had a significant effect on compressibility index, but the positive sign of its coefficient indicated that it resulted in poor flow. These findings are similar to those of Chukwu et. al., who reported the poor flow properties of granules prepared using acacia (21).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Source: Pharmaceutical Technology,
Click here